What is the main difference between IGF-1 LR3 and LL-37 Truncated Variants (KR-12 / KS-30)?

IGF-1 LR3 is primarily classified as a performance compound (growth mediator.). LL-37 Truncated Variants (KR-12 / KS-30) is a recovery compound (shorter active fragments of ll-37 (kr-12, ks-30) with retained antimicrobial activity but lower toxicity.).

Can IGF-1 LR3 and LL-37 Truncated Variants (KR-12 / KS-30) be stacked together?

Some peptide pairs in different categories (e.g., recovery + cognitive) are commonly stacked. Others overlap mechanistically and shouldn't be combined. Always consult a licensed physician before stacking compounds.

Side-by-side comparison

IGF-1 LR3 vs LL-37 Truncated Variants (KR-12 / KS-30)

Growth Mediator. versus Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.

IGF-1 LR3

Performance

Growth Mediator.

Top benefits

✓Muscle hyperplasia
✓Fat loss
✓Recovery

Full IGF-1 LR3 guide→

LL-37 Truncated Variants (KR-12 / KS-30)

Recovery

Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.

Top benefits

✓Antimicrobial activity preserved
✓Lower hemolysis vs full LL-37
✓Wound healing research

Full LL-37 Truncated Variants (KR-12 / KS-30) guide→

Attribute	IGF-1 LR3	LL-37 Truncated Variants (KR-12 / KS-30)
Category	Performance	Recovery
Type	protein	linear
Chain length	83 aa	12 aa
Formula	C400H625N111O115S9	KR-12 fragment of LL-37
Common dose	20-50 mcg	Not established
Frequency	Daily (post-workout)	N/A
Top benefit	Muscle hyperplasia	Antimicrobial activity preserved
Top side-effect	Hypoglycemia	Localized irritation (topical)

⚠

Educational use only

This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.